KB:NYSEKB Financial Group Inc Analysis
Data as of 2026-05-26 - not real-time
$106.28
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
KB Financial Group is trading at $106.28, just below its 20‑day SMA of 106.83 but comfortably above the 50‑day (105.29) and 200‑day (92.87) averages, indicating a short‑term pull‑back within a longer‑term bullish framework. The RSI sits at 50.6, suggesting neutral momentum, while the MACD histogram remains negative, flagging bearish pressure despite an overall bullish trend direction. Valuation metrics are compelling: a trailing P/E of 9.96 versus an industry average of 16.81 and a forward P/E of 8.57 point to the stock being undervalued on earnings grounds, even as the price‑to‑book ratio of 4.09 is relatively high. The dividend yield of 2.9% with a modest 27% payout ratio underscores cash‑flow sustainability, though operating cash flow is currently negative. Volatility is elevated at roughly 31% over the past 30 days and a computed beta of 1.39 signals higher market sensitivity, while the max drawdown of 17.5% reflects recent downside risk. The upside potential of about 22% above the current price, combined with increasing volume, supports a positive medium‑term outlook, even as the annual report filing hints at ongoing strategic positioning across multiple geographies.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near immediate support at $101.09
- Increasing volume indicating interest
- Bearish MACD histogram despite overall bullish trend
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued earnings multiples relative to peers
- Attractive dividend yield with low payout ratio
- Projected upside of ~22% and steady revenue growth of 15%
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustainable dividend and moderate ROE (~10%)
- Exposure to South Korean market and diversified international operations
- Elevated volatility and beta suggesting higher systematic risk
Key Metrics & Analysis
Financial Health
Revenue Growth15.20%
Profit Margin36.58%
P/E Ratio10.0
ROE9.99%
ROA0.76%
P/B Ratio4.1
Op. Cash Flow$-26548566491136
Industry P/E16.8
Technical Analysis
TrendBullish
RSI50.6
Support$101.09
Resistance$111.88
MA 20$106.83
MA 50$105.29
MA 200$92.87
MACDBearish
VolumeIncreasing
Fear & Greed Index91.39
Valuation
Target Price$129.63
Upside/Downside21.97%
GradeUndervalued
TypeBlend
Dividend Yield2.90%
Risk Assessment
Beta1.39
Volatility30.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.